ArticleThe American journal of bioethics : AJOB2020

Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?

Liza-Marie Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.